Proximagen, LLC
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM) (NCT02765165) | Proximagen, LLC | 2016-04-01 |
Track Proximagen, LLC automatically
Every clearance here is in the API, with alerts when new ones post.